Mechanisms underlying methotrexate-induced pulmonary toxicity. - Wikidata - awgldk - TriplyDB

Mechanisms underlying methotrexate-induced pulmonary toxicity.

Mechanisms underlying methotrexate-induced pulmonary toxicity.

http://www.wikidata.org/entity/Q37524010

about

Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering Dietary transforming growth factor-beta 2 (TGF-β2) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat.Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.Antineoplastic therapy-induced pulmonary toxicity.Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937.The toxicity of methotrexate in male fertility and paternal teratogenicity.Pulmonary complications in survivors of childhood hematological malignancies: single-center experience.Protective mechanisms of resveratrol against methotrexate-induced renal damage may involve BCRP/ABCG2.Association of TNFα-308, IFNγ+874, and IL10-1082 gene polymorphisms and the risk of non-small cell lung cancer in the population of the South Indian state of Telangana.

P2860

Q30415505-57EAEDB6-7C51-48A9-B3CF-48B54EEE04D9 Q34416431-5378F5A0-204B-4770-A50A-9F594D9F029F Q38014958-D1834C08-A2AD-4D57-8116-D6B681D4CF9C Q38132247-08F10469-0429-416E-B0A7-38AB88863AC6 Q38649371-8E8E8483-4FBA-4494-9768-B118D94DA241 Q38824866-A80A72C0-2010-41F8-80AC-DBFD7758C2AA Q46208616-082E70C3-0E59-4C21-8C38-C5F6C0149AA8 Q46502320-FC1404C2-3FDB-4D27-92DD-E6FE58CF1CAA Q51711175-0BD7E92A-389D-4DA1-B048-B6FB4BB3CC1A

P2860

Mechanisms underlying methotrexate-induced pulmonary toxicity.

http://www.wikidata.org/entity/Q37524010

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Mechanisms underlying methotrexate-induced pulmonary toxicity.

@en

Mechanisms underlying methotrexate-induced pulmonary toxicity.

@nl

type

label

Mechanisms underlying methotrexate-induced pulmonary toxicity.

@en

Mechanisms underlying methotrexate-induced pulmonary toxicity.

@nl

prefLabel

Mechanisms underlying methotrexate-induced pulmonary toxicity.

@en

Mechanisms underlying methotrexate-induced pulmonary toxicity.

@nl

P1433

Q37524010-540BB5B5-D3AF-476F-9D9B-2F7A0CF6E131

P1476

Q37524010-722CAB22-765A-46F1-92AE-ED0270DEFA23

P2093

Q37524010-29748DBC-4265-45E6-BC29-AB95A3C56CB3

Q37524010-30E0F0A7-E953-4E03-AE0C-5DC6AC656612

Q37524010-E45F2B3C-10F6-4A93-9528-2D179B1689BA

P2860

Q37524010-0500B37D-2E3D-4244-940F-9476D34A88D0

Q37524010-0867A672-75EB-4677-9C28-E9D0DABBD03C

Q37524010-156DB12E-5665-41F2-9856-B41233A17016

Q37524010-16384868-8AA8-457F-9274-A80E3872BDEA

Q37524010-178BE9D3-C958-40EF-B84C-4FBEB118646B

Q37524010-2D051F68-E6AD-462D-BD5E-B2C63F17F5F1

Q37524010-2EC33746-06CA-47EE-9824-F7DD4518F387

Q37524010-3250B7DA-E036-4C22-A803-0EA4CF96DD67

Q37524010-326D59CD-DA4B-48AB-83B0-1D7B5AACFC05

Q37524010-32798A8E-5085-4C24-A8E2-F14441AA3005

P304

Q37524010-456DBAAE-3CDB-4089-A120-C00B774D93FF

P31

Q37524010-C574B377-1E98-4F70-A90C-1E76F91397B9

P356

Q37524010-61E69958-321E-4674-9FBA-B53CA38C28DB

P407

Q37524010-BEB1C094-6D7C-4FC3-877D-9102EBD0644B

P433

Q37524010-C8BC2661-9CB2-4A62-B4C6-9DF126674771

P478

Q37524010-B014A65F-79B6-4DD5-8858-7602BF5B6A04

P577

Q37524010-80C3F2B4-717E-49A1-83F3-5355A583DFC1

P698

Q37524010-D381A3C6-73DC-451B-A559-DC86F0572164

P356

14740330903066734

P1433

Expert Opinion on Drug Safety

P1476

Mechanisms underlying methotrexate-induced pulmonary toxicity.

@en

P2093

Jae-Chun Ryu

http://www.w3.org/2001/XMLSchema#string

Mee Song

http://www.w3.org/2001/XMLSchema#string

Youn-Jung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Gene ontology: tool for the unification of biology

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase

TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta ), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease.

Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8.

Biochemical pathways analysis of microarray results: regulation of myogenesis in pigs.

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

Mechanisms of action of methotrexate.

P304

451-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740330903066734

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19538103

http://www.w3.org/2001/XMLSchema#string